Latest Market Share News

Metcash Limited reported an 8.9% rise in FY25 sales revenue to $17.3 billion and an 8.6% increase in underlying EBITDA, driven by strong Food pillar growth and the acquisition of Superior Foods. However, declines in Liquor and Hardware EBIT tempered overall profit growth.

FOS Capital has satisfied all conditions precedent for its acquisition of Aldridge Traffic Systems, moving the deal towards completion with a revised timetable for share placement.

KMD Brands reports mixed sales across its portfolio with a notable rebound in Kathmandu’s direct-to-consumer sales and robust online growth, while managing tariff uncertainties and margin pressures.

CSL has secured FDA approval for ANDEMBRY®, a pioneering treatment for hereditary angioedema, enabling an immediate US launch with promising clinical results. This milestone marks a significant advance in managing a rare but debilitating condition.

The Calmer Co. has secured a major retail milestone by launching its Fiji Kava 50g Instant Kava product across Woolworths supermarkets nationwide, significantly broadening its Australian footprint.

PointsBet’s board has unanimously dismissed Betr Entertainment’s acquisition proposal, reaffirming that MIXI Australia’s $1.20 per share cash offer remains the superior path forward for shareholders.

Ventia Services Group has locked in a $100 million, five-year contract with Tuatahi First Fibre, reinforcing its role as a key player in New Zealand's fibre infrastructure landscape.

WCM Global Growth Limited has renewed its on-market share buy-back program for 12 months, signaling ongoing confidence in its capital management strategy amid evolving market conditions.

Minbos Resources reports strong 2024-25 field trial results for its phosphate fertilizer PRIMEIRO™ in Angola, while expanding its product range with PRIMEIRO PLUS+, a blended NPKS solution tailored to local soils and crops.

Cochlear Limited has lowered its FY25 earnings guidance due to slower-than-expected sales growth and a sharper decline in Services revenue. Despite this, implant unit growth remains on track, driven by emerging markets.

BluGlass Limited has extended the closing date of its Share Purchase Plan to June 13, 2025, giving eligible shareholders more time to subscribe at a discounted price. The move aims to maximize participation ahead of a crucial shareholder vote.

Zip Co Limited has raised its FY25 cash EBTDA guidance to at least $160 million, driven by robust transaction growth in the US market exceeding 40% year-on-year in May 2025. The company also continues its share buy-back program amid steady credit performance.